ProtAffin Biotechnologie AG
🇦🇹Austria
- Country
- 🇦🇹Austria
- Ownership
- Private
- Established
- 2005-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.protaffin.com
A Phase 1, First in Human Study to Investigate the Safety and Tolerability of PA401
Phase 1
Terminated
- Conditions
- Healthy Volunteers
- Interventions
- Biological: PA401Other: Placebo
- First Posted Date
- 2012-06-25
- Last Posted Date
- 2013-09-23
- Lead Sponsor
- ProtAffin Biotechnologie AG
- Target Recruit Count
- 49
- Registration Number
- NCT01627002
- Locations
- 🇬🇧
Quintiles, London, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath